4.10Open4.10Pre Close0 Volume10 Open Interest20.00Strike Price0.00Turnover0.00%IV3.52%PremiumDec 20, 2024Expiry Date3.52Intrinsic Value100Multiplier28DDays to Expiry0.58Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.85Leverage Ratio--Theta--Rho--Eff Leverage--Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet